Neuromodulation News and Research

RSS

Functional Electrical Stimulation may benefit people with Parkinson's

The use of electrical impulses to stimulate weak or paralyzed muscles, called Functional Electrical Stimulation (FES), is often used to help stroke or multiple sclerosis patients to walk.

2 Jun 2008

Results of St. Jude Medical deep brain stimulation study presented at APA meeting

St. Jude Medical, Inc. today announced pilot study results from the first multi-center study investigating deep brain stimulation (DBS) of Brodmann Area 25 for major depressive disorder.

5 May 2008

St. Jude Medical awarded U.S. patent for neurostimulation therapy for depression

St. Jude Medical, Inc. has announced it has been awarded a patent from the U.S. Patent and Trademark Office for treating depression using neurostimulation therapy in an area of the brain known as Brodmann Area 25.

21 Apr 2008

URMC testing new device for Parkinson's

The University of Rochester Medical Center (URMC) is one of a handful of sites nationwide testing a new device for patients with Parkinson's disease and essential tremor, a neurological movement disorder.

14 Feb 2008

New ANS spinal cord stimulation lead for patients with low back pain

St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) clearance of two spinal cord stimulation tripolar paddle leads for use with the Renew Neurostimulation System.

15 Feb 2007

Advanced Neuromodulation Systems receives European approval for Rapid Programmer

Advanced Neuromodulation Systems (ANS), the neuromodulation business of St. Jude Medical, Inc., has announced European CE Mark approval for its newest clinician programming platform, Rapid Programmer 3.0 for spinal cord stimulation (SCS), an advanced therapy for managing chronic pain.

18 Jan 2007

Advanced Neuromodulation Systems receives Australian approval for rechargeable chronic pain system

Advanced Neuromodulation Systems (ANS), the neuromodulation business of St. Jude Medical, Inc, today announced Australian Therapeutic Goods Administration (TGA) regulatory approval for its Eon Rechargeable Neurostimulation System.

3 Oct 2006

Uroplasty receives FDA approvable letter for treatment of female stress urinary incontinence

Uroplasty, Inc. has announced that it has received an approvable letter from the U.S. Food and Drug Administration (FDA) relating to its pre-market approval (PMA) application for Macroplastique Implants for the treatment of female stress urinary incontinence (SUI).

14 Sep 2006

New York-Presbyterian Hospital offers Vagus Nerve Stimulation (VNS) Therapy

New York-Presbyterian Hospital/Columbia University Medical Center is the first in the greater New York City-area to offer Vagus Nerve Stimulation (VNS) Therapy as a long-term treatment specifically approved by the FDA for treatment-resistant depression (TRD).

7 Nov 2005

Assessment of spinal cord stimulator in treatment of chronic pain

A neurosurgeon at the University of Illinois at Chicago is assessing how well an implanted electronic device that stimulates nerve fibers in the spinal cord relieves chronic pain.

7 Jun 2004